XT
KRYS icon

XTX Topco’s Krystal Biotech KRYS Stock Holding History

XTX Topco’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$417K Sell
1,121
-6,358
-85% -$1.9M 0.01% 2626
2026
Q1 		$1.93M Buy
+7,479
New +$1.99M 0.03% 865
2025
Q1 		– Sell
-2,102
Closed -$329K – 2757
2024
Q4 		$329K Buy
+2,102
New +$373K 0.03% 1139
2023
Q4 		– Sell
-6,793
Closed -$788K – 1860
2023
Q3 		$788K Buy
+6,793
New +$829K 0.13% 180

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

XTX Topco's KRYS Position: Q2 2026 in Review

XTX Topco reduced its Krystal Biotech (KRYS) stake by 85% in Q2 2026, selling an estimated $1.9M and leaving 1,121 shares worth $417K. The position accounts for 0.01% of the portfolio, ranked #2626.

XTX Topco first reported a position in KRYS in Q3 2023 and has held it in 4 quarters since. The position peaked at $1.93M in Q1 2026. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • XTX Topco held 1,121 shares of Krystal Biotech worth $417K as of Q2 2026.
  • XTX Topco sold 6,358 Krystal Biotech shares in Q2 2026, an estimated $1.9M.
  • Krystal Biotech made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2626 holding.
  • XTX Topco first reported a position in Krystal Biotech in Q3 2023 and has held it in 4 quarters since.
  • XTX Topco's Krystal Biotech position peaked at $1.93M in Q1 2026.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.